Technical advances in prenatal diagnosis of tyrosinase-negative oculocutaneous albinism

Acta Dermato-Venereologica

Volumn 77, Issue 1, 1997, Pages 10-13

  Shimizu, H ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

DNA; DOPA; electron microscopy; fetal skin biopsy

Indexed keywords

MONOPHENOL MONOOXYGENASE;

ARTICLE; ELECTRON MICROSCOPY; ENZYME ACTIVITY; HUMAN; MELANOCYTE; OCULOCUTANEOUS ALBINISM; PREGNANCY; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; SKIN TEST; ULTRASTRUCTURE;

ALBINISM, OCULOCUTANEOUS; FEMALE; HISTOCYTOCHEMISTRY; HUMANS; LEVODOPA; MALE; MELANOCYTES; MONOPHENOL MONOOXYGENASE; MUTATION; PREGNANCY; PRENATAL DIAGNOSIS; SKIN;

EID: 0031013749     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. King RA, Summers CG. Albinism. Dermatol Clin 1988; 6: 217 228.
2. Tomita Y. Tyrosinase gene mutations causing oculocutaneous albinisms. J Invest Dermatol 1993; 100: 186s 190s.
3. Oetting WS, King RA. Molecular basis of oculocutaneous albinism. J Invest Dermatol 1994; 113: 131s 136s.
4. Okoro AN. Albinism in Nigeria. A clinical and social study. Br J Dermatol 1975; 92: 485-492.
5. Shapiro MP, Keen P, Cohen L, Murray JF. Skin cancer in the South African Bantu. Br J Cancer 1953; 7: 45 57.
6. Creel DJ, Summers CG, King RA. Visual anomalies associated with albinism. Ophthalmic Paediatr Genet 1990; 11: 193 200.
7. Getting WS, King RA. Molecular basis of type I (tyrosinase-related) oculocutaneous albinism: mutations and polymorphisms of the human tyrosinase gene. Hum Mutat 1993; 2: 1 6.
8. Tomita Y, Takeda A, Okinaga S, Tagami H, Shibahara S. Human oculocutaneous albinism caused by single base insertion in the tyrosinase gene. Biochem Biophys Res Commun 1989; 164: 990 996.
9. Haynes ME, Robertson E. Can oculocutaneous albinism be diagnosed prenatally? Prenat Diagn 1981; 1: 85 89.
10. Eady RA, Gunner DB, Garner A, Rodeck CH. Prenatal diagnosis of oculocutaneous albinism by electron microscopy of fetal skin. J Invest Dermatol 1983; 80: 210 212.
11. Eady RAJ. Prenatal diagnosis of oculocutaneous albinism: implications for other hereditary disorders of pigmentation. Sem Dermatol 1984; 3: 241 246.
12. Holbrook KA. The biology of human fetal skin at ages related to prenatal diagnosis. Pediatr Dermatol 1983; 1: 97 111.
13. Shimizu H, Ishiko A, Kikuchi A, Akiyama M, Suzumori K, Nishikawa T. Prenatal diagnosis of tyrosinase-negative oculocutaneous albinism. Lancet 1992; 340: 739 740.
14. Mishima Y. Electron microscopic cytochemistry of melanosomes and mitochondria. J Histochem Cytochem 1964; 12: 784 790.
15. Shimizu H, Ishiko A, Kikuchi A, Akiyama M, Suzumori K, Nishikawa T. Prenatal diagnosis of tyrosinase-negative oculocutaneous albinism by an electron microscopic DOPA reaction test of fetal skin. Prenat Diagn 1994; 14: 443-450.
16. Akeo K, Shirai S, Okisaka S, Shimizu H, Miyata H, Kikuchi A, et al. Histologie findings of fetal eyes with prenatally diagnosed oculocutaneous albinism. Arch Ophthalmol. in press.
17. Takeda A, Tomita Y, Matsunaga J, Tagami H, Shibahara S. Molecular basis of tyrosinase-negative oculocutaneous albinism. A single base mutation in the tyrosinase gene causing arginine to glutamine substitution at position 59. J Biol Chem 1990; 265: 17792 17797.
18. Shimizu H, Niizeki H, Suzumori K, Aozaki R, Kawaguchi R, Hikiji K, et al. Prenatal diagnosis of oculocutaneous albinism by analysis of the fetal tyrosinase gene. J Invest Dermatol 1994; 103: 104 106.
19. Falik Borenstein TC, Holmes SA, Borochowitz Z. Levin A, Rosenmann A, Spritz RA. DNA-based carrier detection and prenatal diagnosis of tyrosinase-negative oculocutaneous albinism (OCA1A). Prenat Diagn 1995; 15: 345 349.
20. Sybert VP, Holbrook KA, Levy M. Prenatal diagnosis of severe dermatologic diseases. Adv Dermatol 1992; 7: 179 209.
21. Rodeck CH, Nicolaides KH. Fetoscopy and fetal tissue sampling. Br Med Bull 1983; 39: 332 337.